BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent Lab Test Using Its Ygiene(TM) Hospital Grade Antimicrobial BioNeutral Announces 100% Total Kill of Swine Flu (H1N1) on Virtual Contact of This Pandemic Causing Virus in an Independent Lab Test Using Its Ygiene(TM) Hospital Grade Antimicrobial
Aug. 18, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia demonstrated that Ygiene™ Hospital Grade Antimicrobial totally eradicated the H1N1 Swine Flu virus in 20 seconds (Virtual Contact). This independent testing shows that Ygiene™ Hospital Grade Antimicrobial is extremely effective against the Swine Flu. BioNeutral’s Ygiene™ Hospital Grade Antimicrobial is also one of a few antimicrobials actually tested against the specific H1N1 Swine Flu Virus.
On June 11th the World Health Organization (WHO) declared that the original outbreak of Swine Flu (H1N1) had progressed unabated to a global pandemic Level 6, meaning that isolation and control of human to human infection within a single nation or global region was not possible. Current concerns with the Swine Flu are that it may return to North America this fall in an even more resilient viral form. While many current commercial antimicrobials are believed to be effective against the Swine Flu Virus, only a handful have actually been tested against the H1N1 (Swine Flu) Virus. If the Swine Flu Virus reappears in a more resilient mutated viral form, the likelihood increases that the untested antimicrobials currently on the market may not be effective against this virus. In addition, many of today’s commercial antimicrobials require an extremely long contact time of 10 minutes to be effective against the flu virus. In contrast, the Ygiene™ Hospital Grade Antimicrobial, developed by BioNeutral, requires only 20 seconds of contact time, making cleaning and elimination of the virus more realistic in today’s world where speed is of the essence. The speed of BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will meet these time to kill demands.
Recently, former Secretary of Homeland Security, Michael Chertoff and Dr. J. Bennet Waters wrote an article about the problems and issues associated with a pandemic. In the article (chertoffgroup.com) they explain that using old conventional thinking and “treating a pandemic as a health problem is not just bad policy, it is a dangerous approach." Associated with a pandemic are a myriad of diplomatic, economic and national security consequences along with complex operational issues at all levels, in all sectors. Plans to deal with a pandemic must include prevention, detection, response and recovery. BioNeutral believes that its Ygiene™ Hospital Grade Antimicrobial will be an integral part of a comprehensive plan that deals with a pandemic such as the Swine Flu.
BioNeutral Group CEO, Stephen J. Browand, stated "Ygiene is an inexpensive, Green to the environment, non corrosive, non-staining, mild to the touch chemical formulation, which out performs all other antimicrobials and will become the solution of choice once approved by the EPA for commercialization in the United States. The company is in discussions to distribute and license its groundbreaking technology which includes a family of formulations that are all sporicidal.”
Chief Scientist at BioNeutral Group, Dr. Andy Kielbania stated “These independent lab results continue to verify the exceptional efficacy and speed to kill of our Ygiene™ Hospital Grade Antimicrobial. In addition, our strategy of raising the bar on antimicrobial performance includes actually testing against the microorganisms where we intend to make our EPA claims. We prefer not to make claims by extrapolating scientific data since this approach may lead to invalid conclusions.” He continued, “We also believe for an antimicrobial to be effective it must eradicate quickly like the 20 seconds demonstrated by our Ygiene™ Hospital Grade. Based upon all the independent testing results obtained to date on our Ygiene™ antimicrobial, we believe it will also be extremely effective and have a beneficial toxicity profile and a significant cost performance advantage when used in a diluted form against the H1N1 virus. We are currently pursuing this approach. The 10 minute required contact time claimed by many of today’s commercial disinfectants is much too long since those individuals responsible for cleaning areas may not rigorously follow these extended time requirements. Developing our world class antimicrobials with rapid kill times is an important part of our strategy of raising the bar on today’s antimicrobial performance.”
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene™ and Ogiene™, which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral’s proprietary platform technology has been proven effective in surface, water and airborne applications.
Microbiotest Inc. located in Sterling Virginia is a world recognized laboratory with over 20 years of experience in testing a broad spectrum of microbiological materials. Microbiotest effectively collaborates and has an excellent track record with its clients that are developing new products to meet various Agency regulatory requirements using recognized protocols both in North America and abroad. In addition Microbiotest has the ability to design unique tests for special situations.
Forward-Looking Statements
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene™ and are not yet available for sale in the United States.
Source: Business Wire (August 18, 2009 - 8:30 AM EDT)
Posted by Dagny on :
Great news! I already have some of this and it is starting to move already\
Posted by Burberry Boy on :
starting to move easier on big swine flu news
.30(2) by .32(4)
Posted by duckhead on :
real nice news... surprised there isn't more volume...
Posted by Dagny on :
news out about 15 min ago, give it a liitle time
Posted by Burberry Boy on :
yes thats right give it some time and we should pop!
new hod * .32 just hit!
Posted by Burberry Boy on :
.34!
.32(1) by .34(1)
then we have a .35 wall on the ask which could be good because if it takes that down then big momoentum could come in
looking good!
Posted by Burberry Boy on :
.35 buys coming. 4mms left there. if we can get passed this wall...then its very thin after that
Posted by Burberry Boy on :
only 3 left before .35 is broken...really starting to thin out here!
Posted by Burberry Boy on :
2mms at .35
nice buys rolling in
780k vol
Posted by Burberry Boy on :
.35s gone!
.36 getting hit now, starting to move easier
.35(1) by 36(1)
Posted by Dagny on :
volume picking up!
Posted by duckhead on :
I think i just heard a pin drop....
Posted by Burberry Boy on :
.36(1) by .37(1)
3 left to .40
Posted by Burberry Boy on :
37(1) by 38(1)
2 left till .40
Posted by Hot-Pepper on :
I am in
Posted by Dagny on :
Have the other boards been alerted yet?
Posted by Burberry Boy on :
.40 is here...and falling!!
this one is going real fast now!
big buys coming!
wish i would of bought alot more earlier lol
Posted by duckhead on :
yah burberry... I hear ya... I only was able to get 7790 filled for .33 when it was trading at .35... scottie had me by the bawls so i had to call them to get my account straightened out when it was at .32.... Woulda been reaaaaaaal nice if my order was filled all the way But ya can't complain about making money:)
Thanks for the heads up on this one Burberry!
Posted by Burberry Boy on :
havent really alerted anyone except here.
.412 by .419
Posted by Burberry Boy on :
np duckhead.
when i saw the new pre-market i put a buy way over the ask at .31 the bid went up to .28 and the ask to .30
somehow i got filled at .28, i was lucky but didnt get to much. maybe on a dip i will pick up some more
goodluck!
Posted by Burberry Boy on :
so thin now.
every buy moving it up
3mms to .50!
around .50 is the huge break. check out the chart. after about .51-.52 we can really move
lovely chart from here!
Posted by Burberry Boy on :
.44 on ask
3 more mms and it will be .50!
Posted by Burberry Boy on :
heading back up on that dip. hope some got more shares. hit .38 back up to .44
looks like it wants alot more
Posted by Hot-Pepper on :
Dagny, I think because of the price of this stock, the correct thread to be in is this one.
Posted by Dagny on :
Yes you are right, getting a little excited here, just posted on the first thread I came to regarding this stock rocket!!
Posted by Ticker on :
I bought in on this as soon as I saw this news. I didn`t even stop to think:
WOW! I FINALLY MOVED OUT OF SUB-PENNIES!
Posted by Ticker on :
BioNeutral's Ygiene(TM) Achieves World's Fastest Kill Time With a 100% Total Spore Eradication Verified In Independent Sporicida
NEWARK, N.J., Aug. 12 /PRNewswire-FirstCall/ -- BioNeutral Group, Inc. ("BioNeutral") (OTC:BONU) (BULLETIN BOARD: BONU) , a specialty chemical technology-based Life Science company announced today that ATS Labs using the EPA required AOAC Sporicidal Test with Ygiene(TM) Hospital Grade formula delivered a 100% Total Kill of over one million live Clostridium Sporogenes spores in a four (4) minute time frame - performance which is up to 75 times faster than competitive products such as Steris Spor-Klenz RTU.
"The company is in discussions with a global leader in the health care sector to arrange distribution following our regulatory approval," said Stephen J. Browand, CEO BioNeutral Group Inc. "Our health care market alone is very broad and includes every hospital, nursing home, home health care patient, every immune suppressed patient, emergency room, ambulance, first responder, and doctor, dental, and veterinary office."
"Whether it is the present Swine Flu (H1N1) pandemic or the most difficult to kill dangerous organisms, Bioneutral's technology has given rise to the only family of sporicidal formulations for the hospital/health care sector, industry (including schools) and the home. Performance is unsurpassed, it has a Green environmental profile, is non corrosive, non staining to most fabrics (eg sheets and pillow cases) and can come into contact with skin while remaining sporicidal," said Dr Andy Kielbania PhD, BioNeutral's Chief Scientific Officer.
This EPA required AOAC Sporicidal Test utilizing spore impregnated knotted suture loops is an extremely difficult test to pass especially when starting with over one million Clostridium Sporogenes spores. The rapid elimination of these health threatening microorganisms at health care facilities will reduce the incidents of Hospital Acquired Infections (ACI) and the associated loss of lives. Many of today's best known industrial disinfectants, including those commonly used in hospitals and health care facilities, are unable to pass this test at all or require up to several hours of direct wet contact to pass.
Examples of commonly used antimicrobials in health care facilities which cannot claim passing this EPA sporicide/sterilant test include CaviCide and Medica DC 10(TM). While these antimicrobials may eliminate easily eradicated bacteria and some viruses, they have no effect on spores and therefore cannot claim to be sporicidal. Examples of antimicrobials which have passed the EPA required test include Actril Cold Sterilant and Clidox -S which require hours to be effective. Steris Hydrogen Peroxide Sterilant requires special protective equipment and highly trained professionals to correctly apply this antimicrobial. In addition this product requires 90 minutes of direct contact to eliminate spores. Steris Spor-Klenz RTU is easier to apply but can take up to five and one half hours (5.5 hours) to eliminate spores.
A sporicide/sterilant which operates at room temperature with the rapid kill demonstrated by Ygiene(TM) Hospital Grade will provide a substantial economic advantage for future users. Ygiene is easy to use and provides a much quicker turn around time for total sterilization of equipment and facilities. BioNeutral's Ygiene(TM) will reduce the cost of human resources and capital expenditure, decrease turnaround time for surgical procedures and medical facilities thereby maximizing precious resources while providing increased safety for staff and patients alike.
About ATS Labs:
ATS Labs, http://www.ats-labs.com/ is a leading internationally recognized lab used by the developers and users of antimicrobial products. They provide comprehensive antimicrobial service and their superior client service and scientific data have earned them a distinguished record of acceptance with regulatory agencies in the U.S., Canada and the world.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
Contact Information
BioNeutral Group Inc.
Stephen J. Browand, President and CEO
Investor Relations Aimee Boutcher 973 239-2878
DATASOURCE: BioNeutral Group, Inc.
CONTACT: Stephen J. Browand, President and CEO of BioNeutral Group Inc.,
Good luck ticker!! I have made some serious cash on getting out of the sub pennies. I bought some HMA stock at .79/ share, look at it now! Sometimes it is worth it to pay just a little more.
Posted by Burberry Boy on :
beautiful close of .44 with .45 on the ask
could gap over .50 tomorrow and continue its run
congrats to all who got in
Posted by Dagny on :
Well, its doing a belly crawl right now, sold mine yesterday at .43, may buy back in, I still think it has great potential, if it gets contracts to sell these products in major hospitals, but then again,,,IF
Posted by Love the Market on :
More Good NEWS!!
BioNeutral's Consumer Grade Ygiene(TM) Delivers a 100% Total Kill on Contact of Swine Flu (H1N1) Virus
- For the HomeLast update: 8/20/2009 8:30:03 AMNEWARK, N.J., Aug 20, 2009 (BUSINESS WIRE) -- BioNeutral Group, Inc. ("BioNeutral") (BONU), a specialty chemical technology based Life Science Company, announced today that independent lab test results conducted at Microbiotest Inc. of Sterling, Virginia demonstrated that Ygiene(TM) Consumer Grade Antimicrobial (A significantly milder and diluted variation of the Ygiene(TM) Hospital Grade Formulation) totally eradicated the H1N1 Swine Flu Virus in 20 seconds (Virtually on Contact). This independent testing shows that Ygiene(TM) Consumer Grade Antimicrobial equaled the performance of our hospital grade formultaion and is extremely effective against the Swine Flu. It is one of a few antimicrobials actually tested against the specific H1N1 Swine Flu Virus. Commerce Secretary Gary Locke stated, concerning the H1N1 Virus, "Its more than just a significant health issue. It has the potential to affect every aspect of our lives," Locke said. "It will take Americans from every walk of life pulling together and doing our part to mount an effective response." As the first pandemic in more than 40 years, it has the potential to cause massive disruptions for businesses, schools and governments. The United States and other northern nations have been scrambling to prepare for a resurgence of the virus The virus, which first surfaced last spring in Mexico, has spread to at least 168 countries and sickened 177,000. It has contributed to at least 1,462 deaths, including 477 in the United States, and is still circulating in the population. "We are well on our way to achieving our objective to have the fastest acting, least expensive, longest lasting, simple to use, green formulations to eliminate swine flu from home, office, schools and public gathering places," said Dr. Andy Kielbania, chief scientist for Bioneutral Group Inc. "This mild formulation can come into daily contact with skin and clothing providing added protection against H1N1 and other dangerous organisms for the general population and the broader health care sector, as well." These independent lab test results demonstrate that BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will deliver the same speed and efficacy for eradicating the Swine Flu virus as BioNeutral's Ygiene(TM) Hospital Grade Antimicrobial which is designed to eliminate very difficult to kill dangerous organisms in the hospital environment responsible for nosocomial infections. BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will provide household consumers the peace of mind knowing that it will be able to totally eliminate the Swine Flu virus in 20 seconds, virtually on contact, while still being environmentally friendly and gentle to surfaces being cleaned in the home. BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial will contribute to maintaining good family health. This 20 second kill time is also much faster than the 10 minute kill time claimed by many of today's commercially available household disinfectants. BioNeutral Group Inc. CEO, Stephen J. Browand, stated, "BioNeutral's Ygiene(TM) Consumer Grade Antimicrobial is an important addition to the company's growing list of formulations which will be presented to the EPA for regulatory approval." About BioNeutral Group, Inc. Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications. More information about the Company may be found at About Microbiotest Inc. Microbiotest Inc. located in Sterling Virginia is a world recognized laboratory with over 20 years of experience in testing a broad spectrum of microbiological materials. Microbiotest effectively collaborates and has an excellent track record with its clients that are developing new products to meet various Agency regulatory requirements using recognized protocols both in North America and abroad. In addition Microbiotest has the ability to design unique tests for special situations. Forward-Looking Statements BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States. SOURCE: BioNeutral Group, Inc. BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973-239-2878 aboutcher*aol.comCopyright Business Wire 2009
Posted by Ticker on :
So do we invest now, or wait until the product comes out on the market?
I`m in, but was thinking of adding... Posted by Dagny on :
Same here, I sold at .43, was going to buy back, but now I just don't know
Posted by Ticker on :
'Explosion' of Swine Flu Cases Predicted By GILLIAN WONG, AP
posted: 9 HOURS 20 MINUTES AGO
(Aug. 21) — The global spread of swine flu will endanger more lives as it speeds up in the coming months and governments must boost preparations for a swift response to a coming "explosion" of cases, the World Health Organization said Friday. Many countries could see swine flu cases double every three to four days for several months until peak transmission is reached, once cold weather returns to the northern hemisphere, said WHO's Western Pacific director, Shin Young-soo.
"At a certain point, there will seem to be an explosion in case numbers," Shin told a symposium of health officials and experts in Beijing. "It is certain there will be more cases and more deaths."
The WHO says the swine flu virus — also known as H1N1 — has killed almost 1,800 people worldwide, and has declared a pandemic.
International attention has focused on how the pandemic is progressing in southern hemisphere countries such as Australia where winter — and the flu season — has started.
But it is in developing countries that the accelerated spread of swine flu poses the greatest threat as it places underequipped and underfunded health systems under severe strain, Shin said.
WHO earlier estimated that as many as 2 billion people could become infected over the next two years — nearly one-third of the world's population.
Others said Shin's cautionary comments were needed but that they were optimistic the spread would not be that serious.
Ann Moen, an influenza expert with the U.S. Centers for Disease Control and Prevention, said that if current trends continue it is possible that the swine flu pandemic will not be worse than a severe flu season.
"I think the world was preparing for an H5N1 (bird flu) pandemic and we didn't get that. So maybe this is our supreme tabletop exercise, a global sort of practice for something bigger," Moen told The Associated Press.
Health officials and drug makers are considering how to speed up production of a vaccine before the northern hemisphere enters its flu season in coming months. Estimates for when a vaccine will be available range from September to December. Delegates from Bangladesh and Myanmar appealed for help in procuring vaccines or making them more affordable for poorer countries, saying they were left vulnerable while rich nations pre-ordered most of the available stock.
"Developing countries like us, we have to fight this war without vaccines," said Mya Oo, deputy health minister of Myanmar. He urged pharmaceutical companies to consider selling the vaccines to developing countries at just above cost.
WHO's flu chief, Keiji Fukuda, said the agency was working hard on the issue, and noted that two drugmakers had pledged to donate 150 million doses of vaccine to poorer countries by the end of October. He said more research was needed to determine how vaccines will be priced.
"Among the many pandemic response issues, this is probably the most critical issue: how we mobilize the vaccines, how we get them to developing countries," Fukuda said.
WHO has stressed that most cases of swine flu are mild and require no treatment, but the fear is that a rash of new infections could overwhelm hospitals and health authorities, especially in poorer countries.
Shin said governments must quickly educate the public, prepare their health systems to care for severe cases and protect those deemed more vulnerable to prevent unnecessary deaths.
"We only have a short time period to reach the state of preparedness deemed necessary," Shin said. "Communities must be aware before a pandemic strikes as to what they can do to reduce the spread of the virus, and how to obtain early treatment of severe cases."
Pregnant women face a higher risk of complications, and the virus also has more severe effects on people with underlying medical conditions such as asthma, cardiovascular disease, diabetes, autoimmune disorders and diabetes, WHO chief Margaret Chan said in a video address.
The last pandemic — the Hong Kong flu of 1968 — killed about 1 million people. Ordinary flu kills about 250,000 to 500,000 people each year. Swine flu is also continuing to spread during summer in the northern hemisphere. Normally, flu viruses disappear with warm weather, but swine flu is proving to be resilient.
Copyright 2009 The Associated Press. The information contained in the AP news report may not be published, broadcast, rewritten or otherwise distributed without the prior written authority of The Associated Press. Active hyperlinks have been inserted by AOL. 2009-08-21 09:03:50
Posted by duckhead on :
BioNeutral Group Hosts Discussions with Four of the World’s Largest Health Care Companies All Interested in Ygiene™ Sporicidal Antimicrobial Performance on Skin and Surfaces
NEWARK, N.J.--(BUSINESS WIRE)--BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world’s largest health care companies. The discussions included both scientific and business representatives all interested in BioNeutral's game changing technology - "Sporicidal performance on surfaces and skin.” Game changing technology is an infrequent occurrence. However, it is easy to identify and differentiate from the run of the mill or obsolete technology and thus generates intense interest. BioNeutral is in a unique position in that it has not solicited contacts with major players in the antimicrobial and health care arena; instead these well known companies have been contacting BioNeutral to develop partnering relationships...................... continued on link provided
Posted by Hot-Pepper on :
Watch "BONU" along with "HTDS".
Posted by Love the Market on :
.79 now. Will we hit $1.00 today? I lowered my sell order from $1.29 to .73 this morning - but just raised it back up to $1.30 for now!
Posted by Hot-Pepper on :
BioNeutral Group Hosts Discussions with Four of the World's Largest Health Care CompaniesFont size: A | A | A8:30 AM ET 8/24/09 | BusinessWire BioNeutral Group, Inc. ("BioNeutral") (OTCBB:BONU), a specialty chemical technology based Life Science Company, announced discussions with four of the world's largest health care companies. The discussions included both scientific and business representatives all interested in BioNeutral's game changing technology - "Sporicidal performance on surfaces and skin." Game changing technology is an infrequent occurrence. However, it is easy to identify and differentiate from the run of the mill or obsolete technology and thus generates intense interest. BioNeutral is in a unique position in that it has not solicited contacts with major players in the antimicrobial and health care arena; instead these well known companies have been contacting BioNeutral to develop partnering relationships.
Any antimicrobial which is not sporicidal may be a carrier for the dangerous and difficult to kill organisms which may then be transported from person to person (this includes all known alcohol, silver or quat based formulations). For example, Clostridium Difficile spores are associated with hospital acquired infections which results in diverted heath care provider's efforts, millions of dollars in extra expenses and hundreds of thousands of unnecessary deaths annually in the US alone. The best high powered currently used hospital disinfectants based upon quaternary ammonium compounds, silver based disinfectants or alcohol washes are totally ineffective at eradicating Clostridium Difficile (C-diff) spores, resulting in a serious unmet need in the health care arena. BioNeutral's Ygiene(TM) is the clear solution for this serious problem.
Dr. Andy Kielbania, Chief Scientist at BioNeutral Group stated, "Results of in-house testing conducted this past week demonstrated a 30 second kill time for the most difficult to kill spores with a mild formulation that is gentle to skin, surfaces and fabric. These are the best results we have produced thus far."
"When these results are confirmed by independent testing," said one of the health care executives, "It represents a game changer which will determine control of a worldwide antimicrobial health care market."
BioNeutral Group Inc. CEO, Stephen J. Browand, stated, "If game changing technology were presently out there, we would not be inundated with calls from the major players in the healthcare field. Killing low level microorganisms with old, me too technology (alcohol, silver, quats or bleach) has been available for quite some time. Rapidily eliminating dangerous spores such as Clostridium Difficile (C-diff) with our new mild Ygiene(TM) formulation which can be exposed to skin is considered the holy grail of antimicrobial performance. Independent lab testing confirming last week's R&D breakthrough should take approximately three weeks".
BioNeutral Group Inc. has confirmed independent test results which indisputably show the Company's Ygiene(TM) formulations outperform virtually all antimicrobials available when it comes to difficult to kill, dangerous organisms including black mold. Dissimilar to silver, bleach and quat based older technology; BioNeutral's Ygiene(TM) is non corrosive, non-staining, non flammable and completely sporicidal.
About BioNeutral Group, Inc.
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(TM) and Ogiene(TM), which are eco-friendly and include natural and common ingredients which are found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and Chemo Neutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene(TM) and are not yet available for sale in the United States.
SOURCE: BioNeutral Group, Inc.
BioNeutral Group Inc. Stephen J. Browand, President and CEO steve*bioneutralgroup.com or Investor Relations Aimee Boutcher, 973 239-2878 aboutcher*aol.com
Posted by Love the Market on :
This should move up all week!
Posted by Hot-Pepper on :
Today it started and flew to 0.79, then decended to 0.72. We may see another great run before noon or after. I think it's trying to collect more steam after yesterday's activities.
Posted by duckhead on :
BioNeutral Group, Inc. Hires The Investor Relations Group BioNeutral Group, Inc. Hires The Investor Relations Group Aug. 26, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU - News), a specialty chemical technology based life science company, has hired the Investor Relations Group (“IRG”), a thirteen-year-old corporate communications firm based in New York City, to serve as its investor relations and public relations agency.
IRG’s investor relations team will implement competitive analysis strategies and its proprietary database of portfolio managers and equity analysts in the global investment community to increase awareness of BioNeutral’s status as an innovator in the antimicrobial industry. The program will include pre-qualified one-on-one introductions, traditional outreach practices, and strategic advisement. Concurrent with that effort, the public relations team will initiate an outreach campaign targeting editors, writers, and segment producers of local and national trade and consumer online, print, radio, and broadcast media outlets.
IRG’s corporate communications program includes new media and multimedia initiatives that involve the creation of broadcast-ready corporate videos, podcasts, and the creation of social networking, video service, and micro-****ging accounts. The Investor Relations Group was recently honored with a “Stevie Award” for Investor Relations Program of the Year and named a finalist in the Best Media Website category from the 2009 American Business Awards.
“BioNeutral is nearing the registration of our lead Ygiene™ product technology with the EPA,” said Stephen J. Browand, the company’s President and Chief Executive Officer. “This is a very significant milestone in the company’s history and we feel that IRG has the expertise and industry relationships necessary to help us meet our objectives, gain exposure, and ultimately raise our corporate profile. BioNeutral is a unique company with products that have many technical advantages over existing, better-known items currently on the market. We have every confidence in IRG’s ability to successfully communicate our story with the investment community, our shareholders, the media, and the public-at-large.”
Posted by duckhead on :
BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds BioNeutral's Ygiene(TM) Kills Dangerous MRSA in Seconds Aug. 27, 2009 (Business Wire) -- BioNeutral Group, Inc. (“BioNeutral”) (OTCBB:BONU), a specialty chemical technology based life science company, reports that its Ygiene™ Hospital Grade Antimicrobial passed the AOAC Use Dilution test by totally eradicating all five million colony forming units of MRSA in less than one minute (fifty-nine seconds) at room temperature. The required EPA testing procedures occurred at ATS Labs.
MRSA, or Methicillin-resistant Staphylococcus aureus, is a very serious health threatening microorganisms present in many health care facilities and community environments. MRSA is one of the more serious antibiotic resistant heath threatening microorganisms that contributes to Hospital Acquired Infections (HAI’s). In the U.S. alone, over two million people annually are afflicted with Hospital Acquired Infections with approximately one hundred thousand people dying. Worldwide Hospital Acquired Infections are on the rise and will lead to hundreds of thousands needless deaths annually. MRSA is also becoming a serious issue associated with Community Acquired Infections such as school and campus settings. With its power to rapidly and totally eliminate MRSA in less than one minute, BioNeutral’s Ygiene™ Hospital Grade Antimicrobial will be a significant part of the future solution for controlling Hospital Acquired Infections and Community Acquired Infections.
“These independent ATS Labs test results completely validate our internal product development efforts,” said BioNeutral Chief Scientist for BioNeutral, Dr. Andrew Kielbania. “The level of efficacy demonstrated in these independent tests is exceptional. Passing this difficult EPA required test for the elimination of MRSA is consistent with the ability of our Ygiene™ Hospital Grade Antimicrobial to address a very serious unmet need associated with Hospital Acquired Infections in the health care area. We believe our Ygiene™ Hospital Grade Antimicrobial will contribute to the saving of many lives in addition to resources at health care facilities.”
“We often use independent labs to support our in-house work, and are very pleased with these test results,” said Stephen Browand, CEO at BioNeutral. “We use tests that demand exceptional performance from our antimicrobial products. Current disinfectants on the market are clearly not doing the job when it comes to controlling HAIs; we believe that our antimicrobial products will help remedy that unacceptable situation. Given these impressive results, we have every confidence that our Ygiene Hospital Grade Antimicrobial will have a major impact in reducing Hospital Acquired Infections and saving lives while protecting the environment.”
Posted by Love the Market on :
Do we go over $1.00 today?!?!?!?! Hope so.
Good Luck!
Posted by Hot-Pepper on :
Yes we will and I'll get out around then and buy back after expected shades..
Posted by Hot-Pepper on :
I got out at $1.04. When it shades some, I'll buy back. I was a very fun ride, although the ride is not over yet.....
Posted by jasbao on :
I got out at $1.05
Posted by Hot-Pepper on :
Love the market , did you get out or stayed ? The peak for today's run was at $1.18. What a ride !! For those of you who also made money, congratulations !!!
Posted by Hot-Pepper on :
How I wish I did not get out. It's now at $1.45.
Posted by jasbao on :
quote:Originally posted by Hot-Pepper: How I wish I did not get out. It's now at $1.45.
I feel the same way...but I'm not gonna complain about profits. I've been caught holding on to some for to long before.
Posted by micropenny on :
I've been in and out of this one - staying in until after H1N1 (swine) flu runs its course in the fall. 100% kill rate for the virus - still a lot of room to move imo.
Posted by micropenny on :
Skymark Research Initiates Independent Research Coverage On BioNeutral Group, Inc. Friday 08/28/2009 9:47 AM ET - Globenewswire
Skymark Research, a leading provider of small- and micro-cap independent investment research, today initiated coverage on BioNeutral Group, Inc. (OTCBB:BONU). Skymark Research is currently offering a complimentary trial subscription. To view our research go to: www.skymarkresearch.com
About SMR:
Skymark Research is a leading provider of independent investment research in North America. Our services include research analysis on the small- and micro-cap markets, real-time news and financial data, market commentary and the SMR newsletter. Skymark Research's staff of small-cap investment professionals is dedicated to providing the small market's investment community with the tools and avenues necessary to make the important investment decisions. To view our research reports on a complimentary trial basis and take advantage of our other services, go to www.skymarkresearch.com and click on the complimentary trial subscription button on our home page, or go directly to our registration page at www.skymarkresearch.com/signup.php
About BioNeutral Group, Inc. (OTCBB:BONU):
BioNeutral Group, Inc. (OTCBB:BONU) is headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey. BioNeutral Group, Inc. is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene(tm) and Ogiene(tm), which are eco-friendly and include natural and common ingredients which are found in baby products and in everyday foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers. BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
SMR Disclosure:
Skymarkresearch.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell any securities. Skymark Research has not been compensated by any of the above mentioned companies. Please read our report and visit our Web site, www.skymarkresearch.com, for complete risks and disclosures.
CONTACT: Skymark Research Dylan Boyle 202-657-6249 info*skymarkresearch.com
Posted by Love the Market on :
Hot-Pepper: Every time I look at the pps, I feel like I've eaten Green Chilli from New Mexico - laced with pure black peppercorns!!
I was taken out Thursday for 4200 at $1.03 and actually got $1.04 for 800 shares on a $1.03 limit order - so it must have been FLYING. I said $1.03 by lunch on the "Hot Stocks" thread, and I was taken out at 11am!
I made $3,150 on it and was only in less than a week at .43 - Funny (but NOT) I had a buy in Thursday for another 2500 at .70 and CANCELED it at about 3pm to try and buy something else. Didn't get it - BUT BONU dropped to .68 before closing at .73 - so I would have made another $625 and ALMOST woould be recovered from by Eddie Bauer and BHWF losses. Imagine that - I've had 2 doubles and a double 'n a half-er, and I'm still down big over the years - but I've made more in the past 2 months than the past 6 years!
I wish I didn't change my sell down from $1.29 the other day - I put a new order in to buy 8000 at .80 - but it may not drop that low for a bit -This COULD be a $10 stock THIS year, imho. But who knows.....
At $1.50.... I would have almost made up for MANY MANY losses!
Posted by Love the Market on :
Should we all buy back in at $2.00 Monday??? LOL Crap - watch it happen! Hey - we just need to find another one!
UNBELIEVEABLE. I also just saw on FOX's "Fast Money" after the Space Shuttle safely launched - that Fannie and Freddie are over $2.30?? Where the F_ck were WE? I dropped them off my watch list about a month ago -because I thought (I DIDN'T think it out is the problem)because at .80 to $1.10 it was too CRAZY! (I didn't buy them at .34 either)! Don't even get me started on C at $1.00 and BAC at $4.00- ...EWWWWwwwwwwww.
Enjoy your weekend! Steve
Posted by micropenny on :
New York Times article about BONU. Now the company info is out to investors who don't necessarily follow penny stocks. I'm still predicting up through late fall.
From Saturday's New York Times Business News: BioNeutral Group Inc. BONU: OTC Bulletin Board Market; Healthcare/Biotechnology
Company Information BioNeutral Group, Inc., formerly Moonshine Creations, Inc., is a specialty life science company. The Company is focused on commercializing a combinational chemistry-based technology, which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms, including bacteria, viruses and even spores. The formulations, including Ygiene and Ogiene, include natural and common ingredients, which are found in baby products and in every day foods. In March 2009, the Company announced that it formed a wholly owned subsidiary, Advanced Bio-Fiber Treatments Corp., which is focused on utilizing its chemical technology to treat fibers and textiles with anti-chemical and antimicrobial properties. BioNeutral Group Inc. 211 Warren Street Newark NJ 07103 Phone: +1 (973) 286-2899
current asking price is $2.04
Posted by Love the Market on :
Resistance?? I don't think BONU HAS any resistance!?!?!?! Congrats to all of you with big ones who stayed in or got back in Friday!
(I just have to be a happy little pig on this one - but the "What COULD of been and ALMOST was is driving me NUTS....WOuld have wiped out all my losses over the past 6 years)! HAHA
Posted by Dagny on :
I just want to add just a little caution. This stock has been great to me, but they actually are being pumped to the max. If you look at the product "Lysol" you will see that it kills all the germs bonu's product does. H1N1 is not some hard to kill virus, it is the flu virus and can be killed on contact by many products already on the market. They are carrying on like this is the Andromeda strain. This concerns me as they have yet found a market for their product. Not to burst any bubbles, just be careful.
Posted by Hot-Pepper on :
I got in again at $2.18 in the morning. but after I came back from a late lunch with my son in the afternoon, the stock was at $2.45.
This stock is destined to $5.00 before the week is over in my own opinion and may even reach a higher destination than that...again this is in my poor insight opinion. If not, oh well it would be just like other disappointing ones I have wtched over the years. But just be careful and do your own research before purchasing and be cautious!!. Company products and services although similar in some cases are different and are for different purposes and uses.
Posted by duckhead on :
I do agree with Dagny... I think ppl are misreading into the product as I stated on the Hot Stocks forum. If this thing still keeps flying who cares...
But Dagny if you look at the Investor packet from the website I guess it's a "green" product that doesn't cause any corrosion. I haven't done any research on lysol or competitors on how fast and how green they work...
Bioneutral finally just now reached out to me after almost two weeks... If I can get any answers that are relavent I'll post em.
Just a heads up to all. Looking on Ihub someone posted that ***** is now on this stock. I havn't looked at his site to verify but I'd begin to watch this carefully in my personal opinion ... Then again I didn't think she'd run like she has In the end it's your money and who really knows just how far this puppy will go...
Posted by Love the Market on :
All of a sudden - I hate being a happy little pig on this one - from the $3K I made last week, but the "What COULD of been and ALMOST was" - like up $15K; is driving me NUTS....Would have wiped out all my losses over the past 6 years and even put me positive a little.... Hey - could have also gone the other way like so many others do.
CONGRATS and Good Luck to all still in!
Steve
Posted by Hot-Pepper on :
Bonu is taking a dip dip, time to get in or watch to see what it's going to do
Posted by Hot-Pepper on :
I got out at 2.80. I am waiting to get in again. I do not know why it took such a drastic dive. I guess profit takers.
Posted by Hot-Pepper on :
I am back in at 2.30 with more shares
Posted by Hot-Pepper on :
I think it's resting a little today, except that it's down, but still talking loud. imo. When it gets up, we hope to see it fly again. thanks to profit takers.
Posted by Hot-Pepper on :
I guess we are all in to make that same thing...."PROFIT".
Posted by Hot-Pepper on :
BONU Trade News 1.635 0.125 BioNeutral Has Retained DC-Based Law Firm Hogan & Hartson to Manage Its EPA/FDA Regulatory Process
Sep 3, 2009 08:57:00 (ET)
NEWARK, N.J., Sep 03, 2009 (BUSINESS WIRE) -- BioNeutral Group, Inc. (BONU, Trade ) has retained Hogan and Hartson, one of Washington's oldest and most prestigious law firms, to manage its regulatory affairs as it proceeds through the approval process for its technology. Patrick Raher, a senior partner and the chairman of Hogan & Hartson's environmental practice, will serve as lead counsel for the BioNeutral Group.
BioNeutral is a publicly traded specialty life science company that is developing several product lines intended to neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses and spores. Some of its product applications (hard and soft surface sterilants and disinfectancts) will require certification by the Environmental Protection Agency (EPA); others (wound care, acne, sterilization of medical/surgical/dental instruments) will require approval by the Food and Drug Administration (FDA). Other product applications in the pipeline, such as stain removers, cleaners, and rust inhibitors are not regulated. Hogan & Hartson has decades of experience in helping clients achieve efficient certification and approvals in the Federal and state regulatory process.
With more than 1,100 lawyers practicing in 27 offices worldwide, Hogan & Hartson brings multiple practices and offices to bear to provide its clients with exceptional service and creative advice. Working at the intersection of business and government, both domestically and internationally, the firm helps its clients structure and complete their projects and transactions and guides them through the maze of government regulation. The firm also has special expertise in securing, protecting, and defending their clients' intellectual property.
"I have great confidence in Mr. Raher's and his team's professional ability," said Dr. Jeffrey Runge of Washington's Chertoff Group and BioNeutral's senior medical advisor. "As the former head of the National Highway Traffic Safety Administration, I had the opportunity to witness his firm's ability from the perspective of a Federal regulator. They have the highest integrity and clearly understand the regulatory process."
"We are extremely pleased to have this highly experienced and prestigious law firm join our group of platinum advisors to assist us in navigating the complexities of the regulatory process. This move will consolidate our various product registrations and is a key component to our overall business strategy," stated Stephen J. Browand, President & CEO of BioNeutral.
ABOUT BIONEUTRAL GROUP
Headquartered at the New Jersey Institute of Technology/EDC in Newark, New Jersey, BioNeutral Group, Inc., is a chemical technology-based Life Science company that intends to commercialize a combinational chemistry-based technology which can neutralize harmful environmental contaminants, toxins and dangerous micro-organisms including bacteria, viruses, mold, fungi and spores. The formulations, including Ygiene and Ogiene, which are eco-friendly and include natural and common ingredients found in baby products and in every day foods. The Company has combined these widely-used compounds in highly specialized ways to create products that dramatically enhance disinfecting and cleaning results; products include BioNeutralizers and ChemoNeutralizers.
BioNeutral's proprietary platform technology has been proven effective in surface, water and airborne applications.
BioNeutral routinely tests its formulations against those of its competitors. The results are published to let shareholders know how the Company's technology compares with known formulations in the market place. Any product claim for antimicrobial activity requires approval from the EPA or FDA, depending upon where and how the formulations are used. The EPA and FDA have not reviewed or confirmed the Company's data and findings. BioNeutral's antimicrobial formulations will be marketed under the brand name Ygiene and are not yet available for sale in the United States.
Under the Private Securities Litigation Reform Act of 1995: The statements in the press release that relate to the Company's expectations with regard to the future impact on the Company's results from new products in development are forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are subject to risks and uncertainties. Words such as "expects", "intends", "plans", "may", "could", "should", "anticipates", "likely", "believes", and words of similar import also identify forward-looking statements. Forward-looking statements are based on current facts and analyses and other information that are based on forecasts of future results, estimates of amounts not yet determined and assumptions of management. Readers are urged not to place undue reliance on the forward-looking statements, which speak only as of the date of this release. We assume no obligation to update any forward-looking statements in order to reflect any event or circumstance that may arise after the date of this release. Additional information on risks and other factors that may affect the business and financial results of BioNeutral Group can be found in the filings of BioNeutral Group with the U.S. Securities and Exchange Commission.
SOURCE: BioNeutral Group, Inc.
The Investor Relations Group Erika Moran/Tom Caden, 212-825-3210 or Public Relations: Laura Colontrelle, 212-825-3210
Posted by Hot-Pepper on :
Bonu is on it's way to recovery after a very hard fall yesterday and before.
Posted by Hot-Pepper on :
Previous closed at $1.51 Opened at $1.415 Day's Low $1.41 Day's high $2.05 Closed at $1.80 Change $0.29 (19.21%) Asking Price $1.84
Let's see if it will increase the pace more tomorrow. Maybe I'll recover from this one.
Posted by micropenny on :
Back up to $2.15 at close on Friday. Hopefully that helps you recover, Hot Pepper! Bio-Neutral has some heavy hitters in their corner with Hogan and Hartson as attorneys, and Chertoff Group shepherding them through some of the regulatory mazes. They're also helped by the green movement since their products are not caustic.
Posted by Hot-Pepper on :
Micropenny, you are right. I have recovered from the hard fall. Although, there is no trading today due to Labor day Holiday, I hope to see it run again begining tomorrow to $5.00 target before the week is over. There maybe some snagging, we will weather that out along the way. Have a great labor day holiday!!.
![[Smile]](smile.gif)
But ya can't complain about making money:)![[Big Grin]](biggrin.gif)
![[Confused]](confused.gif)
![[Wink]](wink.gif)
and who really knows just how far this puppy will go...